Alesco Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Alesco Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,000	Closed	-$84K	–	94
2014 Q1	$84K	Sell	10,000 -7,000	-41%	-$56.5K	0.01%	89
2013 Q4	$100K	Hold	17,000	–	–	0.01%	83
2013 Q3	$92K	Sell	17,000 -2,000	-11%	-$9.62K	0.01%	75
2013 Q2	$77K	Buy	+19,000	New	+$89.2K	0.01%	76

Other funds holding BDSI

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alesco Advisors's BDSI Position: Q2 2014 in Review

Alesco Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2014, closing a stake of 10,000 shares — an estimated $84K sold.

Alesco Advisors first reported a position in BDSI in Q2 2013 and held it in 4 quarters. The position peaked at $100K in Q4 2013. 112 funds tracked by Wall St. Rank hold BDSI as of Q2 2014.

Alesco Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2014 after selling out during the quarter.
Alesco Advisors sold 10,000 BioDelivery Sciences International, Inc. shares in Q2 2014, an estimated $84K.
Alesco Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 4 quarters.
Alesco Advisors's BioDelivery Sciences International, Inc. position peaked at $100K in Q4 2013.
112 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2014.

Based on Alesco Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.